Impact of comorbidity of chronic obstructive pulmonary disease on cardiovascular events and prognosis in patients with chronic heart failure: A single-center retrospective observational study
Hiroya Hayashi(Metropolitan University), Masafumi Kitakaze(Hanwa Memorial Hospital), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Mari Sakamoto(National Cerebral and Cardiovascular Center), Makoto Sata(National Cerebral and Cardiovascular Center), M Maeda, Makoto Amaki(National Cerebral and Cardiovascular Center), Yasuhiro Izumiya(Kumamoto University), Takuya Hasegawa(National Cerebral and Cardiovascular Center), Minoru Yoshiyama(Osaka City University), Hiroyuki Takahama(Tohoku University), Shin Ito(National Cerebral and Cardiovascular Center), Hiroki Fukuda(National Cerebral and Cardiovascular Center)
Cited by 0
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
|Journal of the American College of Cardiology|2018|673
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
|Circulation|2014|456
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363